The Trump administration's promise of a tough stance on healthcare fraud has been called into question by a recent report from the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG). Despite the administration's claims, the numbers tell a different story, revealing a decline in enforcement activity and a shift in methodology that may be inflating the reported financial haul.
The OIG's semiannual report to Congress, covering October through March, highlights a $5.56 billion in expected recoveries and projected savings over six months, along with the barring of 1,212 individuals and companies from federal healthcare programs. However, this figure comes amidst a significant drop in enforcement activity, with combined criminal and civil actions falling to 604, a decrease from 833 in the previous reporting period. Criminal referrals also dropped to 1,168 from 1,451, and exclusions from Medicare and other federal healthcare programs declined to 1,212, continuing a two-year downward trend from 1,795.
The report's headline financial figure is also the result of a methodology change introduced in early 2025, which combines projected savings with money ordered or agreed to be repaid, rather than cash actually recovered. A glossary in the report notes that the figures should not be interpreted as funds already collected, suggesting that the reported financial haul may be overstated.
This report comes at a time when Vice President JD Vance, HHS Secretary Robert F. Kennedy Jr., and Centers for Medicare & Medicaid Services Administrator Mehmet Oz are promoting an "unrelenting" fight against healthcare fraud. The OIG is now part of a Vance-led White House fraud task force, further emphasizing the administration's commitment to tackling the issue.
However, the administration's claims have been met with skepticism, particularly regarding Oz's assertion that the government identified about $2 billion in improper spending on people in the country illegally. The OIG's report, instead, highlights improper payments to deceased enrollees across 35 states, Puerto Rico, and Washington, D.C., as well as autism-related Medicaid spending that was found to be improper or potentially improper due to documentation errors, unsigned assessments, cloned session notes, uncredentialed staff, and weak oversight.
The report is the first signed by Inspector General T. March Bell, a Republican lawyer confirmed by the Senate in December. Bell's previous experience leading a House investigation into Planned Parenthood and serving in the HHS Office for Civil Rights during Trump's first administration adds a layer of credibility to the report's findings.
In conclusion, while the Trump administration has made significant claims about its efforts to combat healthcare fraud, the OIG's report suggests that the reality may be more nuanced. The decline in enforcement activity and the shift in methodology raise questions about the effectiveness of the administration's approach, and the administration's claims of widespread fraud may be overstated or based on flawed assumptions.
